SCHEMBL10132867

SCHEMBL10132867

COc1cc2cccc(NC(=O)c3c(Br)ccc4c3OCO4)c2cc1OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.47
RAB9A P51151 9/20 0.46
NPC1 O15118 8/20 0.46
SMN1; SMN2 Q16637 6/20 0.46
KDM4E B2RXH2 3/20 0.46
TSHR P16473 3/20 0.46
ALDH1A1 P00352 3/20 0.46
HPGD P15428 3/20 0.46
HSD17B10 Q99714 3/20 0.46
LMNA P02545 2/20 0.46
TP53 P04637 4/20 0.40
P2RX4 Q99571 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
PKM P14618 1/20 0.39
RXFP1 Q9HBX9 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10132615 0.82 RXFP1 (0.46) MAPTRAB9ANPC1SMN1; SMN2KDM4E
SCHEMBL420470 0.81 MAPT (0.44) MAPTRAB9ANPC1SMN1; SMN2KDM4E
SCHEMBL10132634 0.80 RXFP1 (0.45) MAPTRAB9ANPC1SMN1; SMN2KDM4E
SCHEMBL10132597 0.80 RXFP1 (0.45) MAPTRAB9ANPC1SMN1; SMN2KDM4E
SCHEMBL10132623 0.80 ALDH1A1 (0.42) MAPTRAB9ANPC1SMN1; SMN2KDM4E
SCHEMBL10161848 0.80 KDM4E (0.43) MAPTNPC1SMN1; SMN2KDM4EALDH1A1
SCHEMBL10132869 0.79 CYP19A1 (0.36) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL10132874 0.78 KDM4E (0.44) MAPTRAB9ANPC1SMN1; SMN2KDM4E
Benzamide SCHEMBL423609 0.77 MAPT (0.42) MAPTRAB9ANPC1SMN1; SMN2KDM4E
SCHEMBL24469717 0.70 NPC1 (0.37) MAPTRAB9ANPC1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8741917-B2 Benzo [C] phenanthridines as antimicrobial agents RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2014-06-03 US disclosed
US-8741917-B2 Benzo [C] phenanthridines as antimicrobial agents RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2014-06-03 US disclosed
US-20120022061-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS RUGTERS, THE STATE UNIVERSITY OF NEW JERSEY 2012-01-26 US disclosed
US-20120022061-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS RUGTERS, THE STATE UNIVERSITY OF NEW JERSEY 2012-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120022061-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS CCNT1, XPO4, XDH MAPT 4875/4885RAB9A 3576/4885NPC1 2668/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.